Slide background
Nöroloji Anabilim Dalı

Nöroloji Anabilim Dalı


Son İki Yılda Uluslararası Dergilerde Yayınlanan Makaleler

2017
5. özgür, A.; Esen, K.; Kaleağası, H.; Yılmaz, A.; Kara, E.; Yıldız, A. Bilateral thalamic lesions: A pictorial review. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 0-0.
http://dx.doi.org/10.1111/1754-9485.12597
4. Duman, T.; Uluduz, D.; Midi, I.; Bektas, H.; Kablan, Y.; Goksel, B.; Milanlioglu, A.; Necioglu orken, D.; Aluclu, U. A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. ELSEVIER BV, 2017, 1-10.
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.04.020
3. Sevim, S.; Kaleağası, H.; Taşdelen, B. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. ELSEVIER BV, 2017, 16, 40-43.
http://dx.doi.org/10.1016/j.msard.2017.05.010
2. Olgiati, S.; Doğu, O.; Tufekcioglu, Z.; Diler, Y.; Saka, E.; Gultekin, M.; Kaleagasi, H.; Kuipers, D.; Graafland, J. The p.Thr11Met mutation in c19orf12 is frequent among adult Turkish patients with MPAN. PARKINSONISM AND RELATED DISORDERS, 2017, 39, 64-70.
http://dx.doi.org/10.1016/j.parkreldis.2017.03.012
Alıntılanma Sayısı: 1
1. Eryilmaz, I.; Cecener, G.; Erer, S.; Egeli, U.; Tunca, B.; Zarifoglu, M.; Elibol, B.; Bora tokcaer, A.; Saka, E. Epigenetic approach to early-onset Parkinson’s disease: low methylation status of SNCA and PARK2 promoter regions. INFORMA UK LIMITED, 2017, 39, 965-972.
http://dx.doi.org/10.1080/01616412.2017.1368141